APC anti-mouse CD25 Antibody

Product Details

Verified Reactivity

Mouse

Antibody Type

Monoclonal

Host Species

Rat

Immunogen

IL-2-dependent cytolytic mouse T-cell clone B6.1

Formulation

Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.

Preparation

The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.

Concentration

0.2 mg/ml

Storage & Handling

The CD25 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.

Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 10⁶ cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser

Red Laser (633 nm)

Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation^1,2, in vitro blocking of IL-2 binding to low- and high-affinity receptors^1-4, growth inhibition of IL-2-dependent T-cell lines^1-4, in vivo depletion of CD25⁺CD4⁺ Treg cells^5-8,10, and immunohistochemical staining of acetone-fixed frozen sections². PC61 antibody recognizes a different epitope than 3C7 antibody (Cat. No. 101902). For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 102040) with endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered. 

Application References

(PubMed link indicates BioLegend citation)

1. Lowenthal JW, et al. 1985. Nature 315:669. (IP, Block)
2. Ceredig R, et al. 1985. Nature 314:98. (IP, IHC, Block)
3. Lowenthal JW, et al. 1985. J. Immunol. 135:3988. (Block)
4. Moreau JL, et al. 1987. Eur. J. Immunol. 17:929. (Block)
5. Takahashi T, et al. 2000. J. Exp. Med. 192:303. (Deplete)
6. Onizuka S, et al. 1999. Cancer Res. 59:3128. (Deplete)
7. Lei TC, et al. 2005. Blood 105:4865. (Deplete)
8. Pasare C, et al. 2004. Immunity 21:733. (Deplete)
9. León-Ponte M, et al. 2007. Blood 109:3139.
10. Cao OW, et al. 2007. Blood doi:10.1182/blood-2007-02-073304. (Deplete)
11. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719.
12. Liu F, et al. 2011. Arch Toxicol. 85:1383. PubMed
13. Anguela XM, et al. 2013. Diabetes. 62:551. PubMed

Product Citations

1. Schuster M, et al. 2017. J Immunol. 199:920. PubMed
2. Tian J, et al. 2021. Autophagy. 17:2586. PubMed
3. Shi L, et al. 2019. Theranostics. 9:4115. PubMed
4. Lyons J, et al. 2018. PLoS Biol. 16:e2002417. PubMed
5. Prajeeth C,et al. 2017. J Neuroinflammation.. 10.1186/s12974-017-0978-3. PubMed
6. Shibata K, et al. 2022. Nat Commun. 13:6948. PubMed
7. Otano I, et al. 2021. Nat Commun. 12:7296. PubMed
8. Koh CH, et al. 2020. Cancer Immunol Res. 8:698. PubMed
9. Kolbus D, et al. 2011. Immunobiology. 216:663. PubMed
10. Noris M, et al. 2009. J Immunol. 183:4249. PubMed
11. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
12. Waysbort N, et al. 2013. J Immunol. 191:5822. PubMed
13. Gravano D, et al. 2010. PLoS One. 5:e13528. PubMed
14. Annu K, et al. 2020. Sci Rep. 10:2359. PubMed
15. Cheng G, et al. 2021. iScience. 24:102673. PubMed
16. Shi L, et al. 2021. Immunity. . PubMed
17. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
18. Kang TH, et al. 2019. Tissue Eng Regen Med. 16:539. PubMed
19. Sugimoto C, et al. 2022. Elife. 11:. PubMed
20. Stahlhut M, et al. 2021. Sci Rep. 11:5294. PubMed
21. Horikoshi M, et al. 2012. PLoS One. 7:e51215. PubMed
22. Min H, et al. 2015. PLoS One. 10: 0138201. PubMed
23. Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed
24. Zimmermann J, et al. 2017. Eur J Immunol. 10.1002/eji.201747100. PubMed
25. Rengarajan S, et al. 2020. Cell Rep Med. :1. PubMed
26. Bertino P, et al. 2019. Oncoimmunology. 8:1601482. PubMed
27. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
28. Park D, et al. 2020. Cancer Res. 80:4172. PubMed
29. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
30. Wang SS, et al. 2021. Biomedicines. 9:. PubMed
31. Russler-Germain EV, et al. 2021. Elife. 10:. PubMed
32. Zhong W, et al. 2022. Nat Commun. 13:4390. PubMed
33. Chin AL, et al. 2021. Nat Commun. 12:5138. PubMed
34. Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed
35. Glassman CR, et al. 2021. eLife. 10:00. PubMed
36. Dou G, et al. 2020. Sci Adv. 6:eaba2987. PubMed
37. Jing Y, et al. 2020. Sci Adv. 6:eaax9455. PubMed
38. Kim JH, et al. 2019. Mol Med. 25:33. PubMed
39. Bergin SM, et al. 2021. Brain Behav Immun. 95:477. PubMed
40. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
41. Wigren M, et al. 2011. J Intern Med. 269:546. PubMed
42. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
43. Pierini A, et al. 2017. JCI Insight. 2. PubMed
44. Kemp V, et al. 2018. Cancer Gene Ther. 26:268. PubMed
45. Shen M, et al. 2022. Nat Cancer. 3:60. PubMed
46. Webb ER, et al. 2022. iScience. 25:104995. PubMed
47. Glassman CR, et al. 2021. Cell. 184(4):983-999.e24. PubMed
48. Oomizu S, et al. 2012. Clin Immunol. 143:51. PubMed
49. Liu X, et al. 2021. Int J Nanomedicine. 16:5675. PubMed
50. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
51. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
52. Kolev M, et al. 2020. Immunity. 52(3):513-527. PubMed
53. Aftabizadeh M, et al. 2021. JCI Insight. 6:. PubMed
54. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
55. Kang CK, et al. 2021. J Infect Dis. 224:39. PubMed
56. Tu J, et al. 2022. Mol Ther Nucleic Acids. 27:733. PubMed
57. Martomo SA, et al. 2021. Mol Cancer Ther. 1.074305556. PubMed
58. Long C, et al. 2016. Toxicol Sci. 152: 85 - 98. PubMed
59. Baomei Wang et al. 2019. Cell reports. 26(6):1614-1626 . PubMed
60. Nenasheva T, et al. 2017. PLoS One. 12(6):e0178983. PubMed
61. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
62. Ahn SH, et al. 2022. Front Endocrinol (Lausanne). 13:846226. PubMed
63. Kobia FM, et al. 2020. PLoS Biol. 18:e3000850. PubMed
64. Pardo E, et al. 2017. PLoS One. 12(6):e0177472. PubMed
65. Wang T et al. 2018. Immunity. 49(3):504-514 . PubMed
66. Barbet G, et al. 2018. Immunity. 48:584. PubMed
67. Chen X, et al. 2019. Med Sci Monit. 25:5389. PubMed
68. Yue X, et al. 2021. EMBO Rep. 22:e52716. PubMed
69. O'Donoghue GP, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
70. Tsai HI, et al. 2021. EMBO Mol Med. 13:e12834. PubMed
71. Hoover AR, et al. 2022. Clin Transl Med. 12:e937. PubMed
72. Tanaka S, et al. 2016. Appl Envir Microbiol. 82: 2693 - 2699. PubMed
73. Chen C, et al. 2020. Front Cell Neurosci. 14:8. PubMed
74. Niven J, et al. 2019. Cell Rep. 28:21. PubMed
75. Schuster M, et al. 2019. Front Immunol. 10:1583. PubMed
76. Alenazy MF, et al. 2022. PLoS One. 17:e0271689. PubMed
77. Shaikh H, et al. 2021. Front Immunol. 12:689896. PubMed
78. Zheng Y, et al. 2022. J Immunol. 208:501. PubMed
79. Tassi I, et al. 2014. J Immunol. 193:4303. PubMed
80. Wong E, et al. 2015. J Immunol. 194:4130. PubMed
81. Yang X, et al. 2021. Bioact Mater. 3150:6. PubMed
82. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
83. Sun Y, et al. 2022. iScience. 25:104846. PubMed
84. Schulze J, et al. 2021. Stroke. 52:2939. PubMed
85. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
86. Kashiwakura Y, et al. 2020. Clinical & Experimental Immunology. 202(1):119-135. PubMed
87. Deptuch T, et al. 2022. Sci Rep. 12:13480. PubMed
88. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
89. Ye Y, et al. 2020. Genome Med. 0.557638889. PubMed
90. Angelou CC, et al. 2020. Frontiers in Immunology. 2.586805556. PubMed
91. Johnson JL et al. 2018. Immunity. 48(2):243-257 . PubMed
92. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
93. Erens C, et al. 2022. Biomedicines. 10:. PubMed
94. Hester AK, et al. 2022. Cell Rep. 38:110363. PubMed
95. Park JS, et al. 2022. J Transl Med. 20:85. PubMed
96. Rana MN, et al. 2021. Front Pharmacol. 12:643215. PubMed

RRID

AB_312860 (BioLegend Cat. No. 102011)
AB_312861 (BioLegend Cat. No. 102012)

Antigen Details

Structure

Forms high affinity IL-2R with IL-2Rβ (CD122) and IL-2Rγ (CD132), 55 kD

Distribution

Activated T cells and B cells, thymocyte subset, pre-B cells, T regulatory cells

Function

IL-2 receptor

Ligand/Receptor

IL-2

Cell Type

B cells, T cells, Thymocytes, Tregs

Biology Area

Immunology

Molecular Family

CD Molecules, Cytokine/Chemokine Receptors

Antigen References

1. Taniguchi T, et al. 1993. Cell 73:5-8.
2. Waldmann TA. 1991. J Biol Chem. 266:2681-4.
3. Read S, et al. 2000. J Exp Med. 192:295-302.
4. Lowenthal JW, et al. 1985. J Immunol. 135:3988-94.

Gene ID

16184 View all products for this Gene ID

UniProt

View information about CD25 on UniProt.org

Documentation

• Technical data sheet
• Certificate of Analysis
• Material Safety Data Sheet

Reviews

Related Protocols

• Cell Surface Flow Cytometry Staining Protocol

Related Pages & Pathways

Related FAQs

Other Formats

Certificate of Analysis